Company Filing History:
Years Active: 2020
Title: Junxia Qiu: Innovator in Pharmaceutical Compounds
Introduction
Junxia Qiu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific protein kinases. His work is crucial in addressing diseases associated with these proteins.
Latest Patents
Junxia Qiu holds a patent for a quinolyl-substituted carboxylic acid compound or a pharmaceutically acceptable salt thereof. This patent, which is categorized under 1 patent, includes a pharmaceutical composition and outlines the use of the compound. The compound serves as an inhibitor for AXL and/or VEGFR2 protein kinases, which are implicated in various diseases, including tumors.
Career Highlights
Qiu is associated with Beijing Konruns Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research and development. His innovative approach has led to advancements in treatments for conditions caused by abnormalities in specific protein kinases.
Collaborations
He collaborates with notable colleagues, including Zhiqiang Zhang and Xijuan Wang, to further enhance the research and development efforts within the company.
Conclusion
Junxia Qiu's contributions to pharmaceutical innovations highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for new treatments that can significantly impact patient care.